CYPHERPUNK TECHNOLOGIES INC. Increase (Decrease) in Deferred Income Taxes
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Increase (Decrease) in Deferred Income Taxes of -$152.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2024-03-18
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred income taxes for fiscal 2022 was -$152.00K.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred income taxes for fiscal 2021 was -$11.00K, a 130.56% decline from fiscal 2020.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred income taxes for fiscal 2020 was $36.00K, a 1100.00% increase from fiscal 2019.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in deferred income taxes for fiscal 2019 was $3.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|
| 2022-12-31 | -$152.00K 10-K · filed 2024-03-18 |
| 2021-12-31 | -$11.00K 10-K · filed 2023-03-24 |
| 2020-12-31 | $36.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | $3.00K 10-K · filed 2021-03-12 |
| 2018-12-31 | -$20.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $158.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |